中药调节肠道菌群干预 2 型糖尿病合并骨质疏松患者的 影响研究.

Study on the effect of traditional Chinese medicine regulating intestinal flora on type 2 diabetes patients with osteoporosis.

Objective To study the effect of traditional Chinese medicine regulating intestinal flora on patients with type 2 diabetes with osteoporosis. Methods A total of 100 patients diagnosed with type 2 diabetes with osteoporosis from September 2017 to December 2019 were selected and randomly divided into observation group and control group, with 50 cases in each group according to the random number table. Patients in the control group used drugs to control blood sugar, blood pressure, and blood lipids according to the condition. In addition, oral vitamin D and calcium were given to supplement calcium. For patients with obvious bone pain, zoledronic acid 5 mg (100 ml.) was intravenously infused, with drip time > 2 h, and drip once only in this study period. According to TCM syndrome differentiation. Liujunzi decoction was used for the spleen and stomach qi deficiency type. Zuoguiwan was used for the liver and kidney yin deficiency type, and compound kidney-invigorating decoction was used for the kidney deficiency and blood stasis type. In the observation group, root of kudzu vine and Qinlian decoction was additioned to all patients on the basis of above-mentioned treatment plan. 28-day oral administration of traditional Chinese medicine was a course of treatment. it was 94.0% in the observation group. Comparing the two groups, the total efficacy in the observation group was higher than that in the control group (P<0.05). E. coli, bifido bacteria and lactobacilli in the observation group improved significantly better than that in control group (all P<0.01). The improvement of glucose metabolism index, bone mineral density, osteocalcin, and blood phosphorns in the observation group was better than that in the control group (P<0.05 or <0.01). Conclusion On the basis of syndrome differentiation and treatment, the treatment of type 2 diabetes mellitus with osteoporosis patients with traditional Chinese medicine that regulates intestinal flora can significantly ameliorate clinical symptoms and biochemical indicators. [ABSTRACT FROM AUTHOR]

目的 研究中药调节肠道菌群对 2 型糖尿病合并骨质疏松患者的影响。方法选择 2017 年 9 月至 2019 年 12 月诊断 为 2 型糖尿病合并骨质疏松的患者共 100 例,根据随机数字表随机分为观察组和对照组各 50 例。对照组患者采用药物控制 血糖,并根据病情控制血压、血脂等,在此基础上予口服维生素 D 和钙剂以补钙.对于骨痛明显者,予静脉滴注唑来膦酸 5mg (100 mL) 静滴时间 >2h,一次滴完(本研究周期内仅注射一次)。根据中医辨证,对脾胃气虚型采用六君子汤加减,肝肾阴虚 型采用左归丸加减,对肾虚血瘀型采用补肾活血剂加减。观察组在上述治疗方案上,对所有患者在中药方剂中加入葛根芩连 汤。中药口服 28d 为 1个疗程,治疗 2个疗程后观察疗效。结果对照组总有效率为 80.0%, 观察组总有效率为 94.0%, 两 组比较,观察组总有效率高于对照组( P<0.05); 观察组大肠杆菌､双歧杆菌和乳酸杆菌改善程度均显著优于对照组 (P均< 0.01); 观察组糖代谢指标,骨密度,骨钙素和血磷改善程度优于对照组 (P<0.05 或<0.01) 结论 在辨证论治的基础上,采 用具有调节肠道菌群的中药治疗2型糖尿病合并骨质疏松患者,可显著改善临床症状和生化指标。 [ABSTRACT FROM AUTHOR]

Copyright of Chinese Journal of Osteoporosis is the property of Chinese Journal of Osteoporosis and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)